Good day, and welcome to the Vertex Pharmaceuticals third quarter 2024 earnings call. All participants will be in a ...

Good day and welcome to the Vertex Pharmaceuticals third-quarter 2024 earnings call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to ...

Companies announce stock splits all the time, and so far this year a number of high profile companies have divvied up their ...

And welcome to the Vertex Pharmaceuticals Third Quarter 2024 ... The call is being recorded and a replay will be available on our website. We will make forward-looking statements on this call ...

Q3 2024 Earnings Call Transcript November 4, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.38, expectations were $4.14. Operator: Good day. And welcome to ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor ...

BOSTON - Vertex Pharmaceuticals (NASDAQ ... with a live webcast available on their website. Acute pain affects millions annually in the U.S., and the need for effective management options is ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral, highly ...

Vertex Pharmaceuticals Incorporated (Nasdaq ... Exchange Commission at www.sec.gov and available through the company's website at www.vrtx.com. You should not place undue reliance on these ...

Under Strategic Platform License (SPL) agreements, the company worked with Vertex Pharmaceuticals and CRISPR Therapeutics ... under “SEC Filings” on the Investors page of our website at ...